Resultados globales: 3 registros encontrados en 0.02 segundos.
Artículos, Encontrados 3 registros
Artículos Encontrados 3 registros  
1.
18 p, 3.7 MB The KMT2A recombinome of acute leukemias in 2023 / Meyer, Claus (DCAL/Institute of Pharm. Biology. Goethe-University(Alemanya)) ; Larghero, Patrizia (DCAL/Institute of Pharm. Biology. Goethe-University (Alemanya)) ; Lopes, BA. (DCAL/Institute of Pharm. Biology. Goethe-University (Alemanya)) ; Burmeister, Thomas (Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany) ; Gröger, Daniela (Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin (Alemanya)) ; Sutton, Rosemary (Molecular Diagnostics. Children's Cancer Institute. Lowy Cancer Research Centre. UNSW (Sidney, Austràlia)) ; Venn, Nicola C. (Molecular Diagnostics. Children's Cancer Institute. Lowy Cancer Research Centre. UNSW (Sidney, Austràlia)) ; Cazzaniga, Giovanni (University of Milano-Bicocca/Fondazione Tettamanti (Itàlia)) ; Corral Abascal, Lilia (University of Milano-Bicocca/Fondazione Tettamanti (Itàlia)) ; Tsaur, Grigory А. (Research Institute of Medical Cell Technologies (Ekaterinburg, Rússia)) ; Fechina, Larisa G. (Research Institute of Medical Cell Technologies (Ekaterinburg, Rússia)) ; Emerenciano, Mariana (Instituto Nacional de Câncer (INCA)(Rio de Janeiro, Brasil)) ; Pombo-de-Oliveira, Maria S. (Instituto Nacional de Câncer (INCA)(Rio de Janeiro, Brasil)) ; Lund-Aho, Tiina (Laboratory of Clinical Genetics, Fimlab Laboratories (Tampere, Finlàndia)) ; Lundán, Tuija (University of Turku and Turku University Hospital (Turku, Finlàndia)) ; Montonen, M. (University of Turku and Turku University Hospital (Turku, Finlàndia)) ; Juvonen, Vesa (University of Turku and Turku University Hospital (Turku, Finlàndia)) ; Zuna, Jan (Charles University and University Hospital Motol (Praga, República Txeca)) ; Trka, Jan M. (Charles University and University Hospital Motol (Praga, República Txeca)) ; Ballerini, Paola (Pierre et Marie Curie University (París, França)) ; Lapillonne, Hélène (Pierre et Marie Curie University (París, França)) ; Van der Velden, Vincent (University Medical Center Rotterdam (Països Baixos)) ; Sonneveld, Edwin (Princess Máxima Center for Pediatric Oncology (Utrecht, Països Baixos)) ; Delabesse, Éric C. M. (Institut Universitaire du Cancer de Toulouse (França)) ; Capela de Matos, Roberto (National Cancer Institute (INCA) (Rio de Janeiro, Brasil)) ; Silva, Maria Luiza (National Cancer Institute (INCA) (Rio de Janeiro, Brasil)) ; Bomken, Simon (Newcastle University, Newcastle upon Tyne (Regne Unit)) ; Katsibardi, Katerina (National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital (Atenes, Grècia)) ; Keernik, Maria (Tartu University Hospital (Tartu, Estònia)) ; Grardel, Nathalie (University Hospital Claude Huriez) ; Mason, J. (Newcastle University and the Great North Children's West Midlands Regional Genetics Laboratory (Regne Unit)) ; Price, Richard (Newcastle University and the Great North Children's West Midlands Regional Genetics Laboratory (Regne Unit)) ; Kim, J. (DCAL/Institute of Pharm. Biology. Goethe-University (Alemanya)) ; Eckert, Cornelia (Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin (Alemanya)) ; Lo Nigro, Luca (Centro di Riferimento Regionale di Ematologia ed Oncologia Pediatrica, Azienda Policlinico "G. Rodolico" (Catània, Itàlia)) ; Bueno, Clara (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Menéndez Bujan, Pablo (Centro di Riferimento Regionale di Ematologia ed Oncologia Pediatrica, Azienda Policlinico "G. Rodolico" (Catània, Itàlia)) ; Zur Stadt, Udo (University Medical Center Hamburg-Eppendorf (Hamburg, Alemanya)) ; Gameiro, Paula (Instituto Português de Oncologia, Departament of Hematology (Lisboa, Portugal)) ; Sedek, Łukasz (Medical University of Silesia (Zabrze, Polònia)) ; Szczepanski, Tomasz (Medical University of Silesia (Zabrze, Polònia)) ; Bidet, A. (Laboratoire d'Hématologie Biologique, CHU Bordeaux (França)) ; Marcu, Victoria (Hematology Laboratory, Sheba Medical Center, Tel-Hashomer, Israel) ; Shichrur, Keren (Schneider Children's Medical Center of Israel, Petah Tikva, Israel) ; Izraeli, Shai (Tel Aviv University, Tel Aviv, Israel) ; Madsen, Hans Ole (Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark) ; Schäfer, Beat (University Children's Hospital Zurich (Zúric, Suïssa)) ; Kubetzko, Susanne (University Children's Hospital Zurich (Zúric, Suïssa)) ; Kim, Rathana (Université Paris Cité (França)) ; Clappier, Emmanuelle (Université Paris Cité (França)) ; Trautmann, Heiko (University Hospital Schleswig-Holstein (Kiel, Alemanya)) ; Brüggemann, Monika (University Hospital Schleswig-Holstein (Kiel, Alemanya)) ; Archer, Paul (Bristol Genetics Laboratory, North Bristol NHS Trust (Bristol, Regne Unit)) ; Hancock, Jeremy P. (Bristol Genetics Laboratory, North Bristol NHS Trust (Bristol, Regne Unit)) ; Alten, Julia (University Hospital Schleswig-Holstein (Kiel, Alemanya)) ; Möricke, Anja (University Hospital Schleswig-Holstein (Kiel, Alemanya)) ; Stanulla, Martin (Department of Pediatrics, MHH (Hanover, Alemanya)) ; Lentes, Jana (Medical School Hannover (Alemanya)) ; Bergmann, Anke K. (Medical School Hannover (Alemanya)) ; Strehl, Sabine (St. Anna Children's Cancer Research Institute (CCRI) (Vienna, Àustria)) ; Köhrer, Stefan (St. Anna Children's Cancer Research Institute (CCRI) (Vienna, Àustria)) ; Nebral, Karin (St. Anna Children's Cancer Research Institute (CCRI) (Vienna, Àustria)) ; Dworzak, Michael Norbert (St. Anna Children's Cancer Research Institute (CCRI) (Vienna, Àustria)) ; Haas, Oskar A. (St. Anna Children's Cancer Research Institute (CCRI) (Vienna, Àustria)) ; Arfeuille, Chloe (Hopital Robert Debré (París, França)) ; Caye Eude, Aurélie (Hopital Robert Debré (París, França)) ; Cavé, Hélène (Hopital Robert Debré (París, França)) ; Marschalek, Rolf (Goethe-University (Alemanya))
Chromosomal rearrangements of the human KMT2A/MLL gene are associated with de novo as well as therapy-induced infant, pediatric, and adult acute leukemias. Here, we present the data obtained from 3401 acute leukemia patients that have been analyzed between 2003 and 2022. [...]
2023 - 10.1038/s41375-023-01877-1
Leukemia, Vol. 37 Núm. 5 (may 2023) , p. 988-1005  
2.
13 p, 2.6 MB Engraftment characterization of risk-stratified AML in NSGS mice / Díaz de la Guardia, Rafael (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Velasco-Hernández, Talia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Gutiérrez-Agüera, Francisco (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Roca Ho, Heleia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Molina, Oscar (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Nombela-Arrieta, Cesar (Department of Medical Oncology and Hematology. University and University Hospital Zurich) ; Bataller, Alex (Hospital Clínic i Provincial de Barcelona) ; Fuster, José Luis (Instituto Murciano de Investigación Biosanitaria) ; Anguita, Eduardo (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ; Vives, Susana (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Zamora, Lurdes (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Nomdedeu, Josep (Institut d'Investigació Biomèdica Sant Pau) ; Gomez Casares, Maria Teresa (Hospital Universitario de Gran Canaria Dr. Negrín) ; Ramírez, Manuel (Instituto de Investigación Hospital Universitario de la Princesa) ; Lapillonne, Hélène (Haematology Laboratory. AP-HP. Hôpital Armand Trousseau. Centre de Recherche Saint-Antoine CRSA. INSERM. Sorbonne Université) ; Ramos-Mejia, Verónica (GENYO. Centre for Genomics and Oncological Research. Pfizer/Universidad de Granada/Junta de Andalucía) ; Rodríguez-Manzaneque, Juan Carlos (GENYO. Centre for Genomics and Oncological Research. Pfizer/Universidad de Granada/Junta de Andalucía) ; Bueno, Clara (Centro de Investigación Biomédica en Red de Cáncer) ; Lopez-Millan, Belen (GENYO. Centre for Genomics and Oncological Research. Pfizer/Universidad de Granada/Junta de Andalucía) ; Menéndez Bujan, Pablo (Institució Catalana de Recerca i Estudis Avançats)
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. Disease heterogeneity is well documented, and patient stratification determines treatment decisions. Patient-derived xenografts (PDXs) from risk-stratified AML are crucial for studying AML biology and testing novel therapeutics. [...]
2021 - 10.1182/bloodadvances.2020003958
Blood advances, Vol. 5 Núm. 23 (14 2021) , p. 4842-4854  
3.
5 p, 653.8 KB Bone marrow clonogenic myeloid progenitors from NPM1-mutated AML patients do not harbor the NPM1 mutation : Implication for the cell-of-origin of NPM1+ AML / Díaz de la Guardia, Rafael (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; González-silva, L. (Instituto de Biomedicina y Biotecnología de Cantabria. Universidad de Cantabria-CSIC) ; López-Millán, Belén (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Rodriguez-Sevilla, Juan Jose (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Baroni, Matteo Libero (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Bueno, Clara (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Anguita, Eduardo (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ; Vives Polo, Susana (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Palomo Sanchís, Laura (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Lapillonne, Hélène (Sorbonne Université. INSERM. Centre de recherche Saint-Antoine CRSA. AP-HP. Hôspital Armand Trousseau. Haematology Laboratory) ; Varela, Ignacio (Instituto de Biomedicina y Biotecnología de Cantabria. Universidad de Cantabria-CSIC) ; Menéndez Bujan, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Universitat Autònoma de Barcelona
The cell-of-origin of NPM1- and FLT3-mutated acute myeloid leukemia (AML) is still a matter of debate. Here, we combined in vitro clonogenic assays with targeted sequencing to gain further insights into the cell-of-origin of NPM1 and FLT3-ITD-mutated AML in diagnostic bone marrow (BM) from nine NPM1+/FLT3-ITD (+/−) AMLs. [...]
2020 - 10.3390/genes11010073
Genes, Vol. 11 Núm. 1 (2020) , p. 73  

Vea también: autores con nombres similares
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.